The largest obstacle to the cost-competitive production of low-value and high-impact biofuels and biochemicals (called biocommodities) is high production costs catalyzed by microbes due to their ...inherent weaknesses, such as low product yield, slow reaction rate, high separation cost, intolerance to toxic products, and so on. This predominant whole-cell platform suffers from a mismatch between the primary goal of living microbes – cell proliferation and the desired biomanufacturing goal – desired products (not cell mass most times). In vitro synthetic biosystems consist of numerous enzymes as building bricks, enzyme complexes as building modules, and/or (biomimetic) coenzymes, which are assembled into synthetic enzymatic pathways for implementing complicated bioreactions. They emerge as an alternative solution for accomplishing a desired biotransformation without concerns of cell proliferation, complicated cellular regulation, and side-product formation. In addition to the most important advantage – high product yield, in vitro synthetic biosystems feature several other biomanufacturing advantages, such as fast reaction rate, easy product separation, open process control, broad reaction condition, tolerance to toxic substrates or products, and so on. In this perspective review, the general design rules of in vitro synthetic pathways are presented with eight supporting examples: hydrogen, n-butanol, isobutanol, electricity, starch, lactate,1,3-propanediol, and poly-3-hydroxylbutyrate. Also, a detailed economic analysis for enzymatic hydrogen production from carbohydrates is presented to illustrate some advantages of this system and the remaining challenges. Great market potentials will motivate worldwide efforts from multiple disciplines (i.e., chemistry, biology and engineering) to address the remaining obstacles pertaining to cost and stability of enzymes and coenzymes, standardized building parts and modules, biomimetic coenzymes, biosystem optimization, and scale-up, soon.
Full text
Available for:
GEOZS, IJS, IMTLJ, KILJ, KISLJ, NUK, OILJ, PNG, SAZU, SBCE, SBJE, UL, UM, UPCLJ, UPUK
Biomanufacturing: history and perspective Zhang, Yi-Heng Percival; Sun, Jibin; Ma, Yanhe
Journal of Industrial Microbiology & Biotechnology,
05/2017, Volume:
44, Issue:
4-5
Journal Article, Book Review
Peer reviewed
Biomanufacturing is a type of manufacturing that utilizes biological systems (e.g., living microorganisms, resting cells, animal cells, plant cells, tissues, enzymes, or in vitro synthetic ...(enzymatic) systems) to produce commercially important biomolecules for use in the agricultural, food, material, energy, and pharmaceutical industries. History of biomanufacturing could be classified into the three revolutions in terms of respective product types (mainly), production platforms, and research technologies. Biomanufacturing 1.0 focuses on the production of primary metabolites (e.g., butanol, acetone, ethanol, citric acid) by using mono-culture fermentation; biomanufacturing 2.0 focuses on the production of secondary metabolites (e.g., penicillin, streptomycin) by using a dedicated mutant and aerobic submerged liquid fermentation; and biomanufacturing 3.0 focuses on the production of large-size biomolecules—proteins and enzymes (e.g., erythropoietin, insulin, growth hormone, amylase, DNA polymerase) by using recombinant DNA technology and advanced cell culture. Biomanufacturing 4.0 could focus on new products, for example, human tissues or cells made by regenerative medicine, artificial starch made by in vitro synthetic biosystems, isobutanol fermented by metabolic engineering, and synthetic biology-driven microorganisms, as well as exiting products produced by far better approaches. Biomanufacturing 4.0 would help address some of the most important challenges of humankind, such as food security, energy security and sustainability, water crisis, climate change, health issues, and conflict related to the energy, food, and water nexus.
Full text
Available for:
CEKLJ, DOBA, FZAB, GEOZS, IJS, IMTLJ, IZUM, KILJ, KISLJ, MFDPS, NUK, OBVAL, OILJ, PILJ, PNG, SAZU, SBCE, SBJE, SBMB, SBNM, SIK, UILJ, UKNU, UL, UM, UPUK, VKSCE, ZAGLJ
Information pertaining to enzymatic hydrolysis of cellulose by noncomplexed cellulase enzyme systems is reviewed with a particular emphasis on development of aggregated understanding incorporating ...substrate features in addition to concentration and multiple cellulase components. Topics considered include properties of cellulose, adsorption, cellulose hydrolysis, and quantitative models. A classification scheme is proposed for quantitative models for enzymatic hydrolysis of cellulose based on the number of solubilizing activities and substrate state variables included. We suggest that it is timely to revisit and reinvigorate functional modeling of cellulose hydrolysis, and that this would be highly beneficial if not necessary in order to bring to bear the large volume of information available on cellulase components on the primary applications that motivate interest in the subject.
Full text
Available for:
BFBNIB, FZAB, GIS, IJS, KILJ, NLZOH, NUK, OILJ, SAZU, SBCE, SBMB, UL, UM, UPUK
Display omitted
•Cellobiose is a zero-calorie sweetener and dietary fiber.•Value-added cellobiose was synthesized from sucrose by an enzyme cocktail.•A kinetic model was developed for data ...accommodation and process optimization.•Use of thermophilic enzymes at elevated temperatures increases reaction rate.
Cellobiose is a zero-calorie functional sweetener and a potential healthy food/feed additive. Current production methods of cellobiose from high-purity cellulose always suffer from low product yields and high separation costs. Here one-pot biotransformation composed of three thermophilic enzymes sucrose phosphorylase (SP) from Thermoanaerobacterium thermosaccharolyticum, glucose isomerase (GI) from Streptomyces murinus, and cellobiose phosphorylase (CBP) from Clostridium thermocellum was designed to convert sucrose to cellobiose. To reveal the underlying relationship within the three enzymes and optimize reaction conditions, a kinetic model was developed. Model simulation predicted the optimal SP:GI:CBP enzyme loading ratio in terms of enzyme unit was 0.5:1.0:1.5. The enzyme cocktail with the optimal ratio converted 100mM sucrose to 62.3mM cellobiose within 10h. Model simulation also found out that the optimal phosphate concentration was approximately 10.3mM for 100mM sucrose, which was validated by experimental data. This study could assist the sugar industry to diversify the production of new value-added products from sucrose.
Full text
Available for:
GEOZS, IJS, IMTLJ, KILJ, KISLJ, NUK, OILJ, PNG, SAZU, SBCE, SBJE, UL, UM, UPCLJ, UPUK, ZRSKP
Fructose 1,6-diphosphate (FDP) is a widely used medicine and is also a precursor of two important three-carbon phosphates – glyceraldehyde 3-phosphate (GA3P) and dihydroxyacetone phosphate (DHAP) for ...the biosynthesis of numerous fine chemicals. An in vitro synthetic cofactor-free enzymatic pathway comprised of four hyperthermophilic enzymes was designed to produce FDP from starch and pyrophosphate. All of four hyperthermophilic enzymes (i.e., alpha-glucan phosphorylase from Thermotaga maritima, phosphoglucomutase from Thermococcus kodakarensis, glucose 6-phosphate isomerase from Thermus thermophilus, and pyrophosphate phosphofructokinase from T. maritima) were overexpressed in E. coli BL21(DE3) and purified by simple heat precipitation. The optimal pH and temperature of one-pot biosynthesis were 7.2 and 70°C, respectively. The optimal enzyme ratios of αGP, PGM, PGI and PFK were 2:2:1:2 in terms of units. Via step-wise addition of new substrates, up to 125 ± 4.6mM FDP was synthesized after 7-h reaction. This de novo ATP-free enzymatic pathway comprised of all hyperthermophilic enzymes could drastically decrease the manufacturing costs of FDP and its derivatives GA3P and DHAP, better than those catalyzed by ATP-regeneration cascade biocatalysis, the use of mesophilic enzymes, whole cell lysates, and microbial cell factories.
•A novel in vitro pathway was designed for the production of A high-energy metabolite without use of ATP.•A set of hyperthermophilic enzymes were applied and the reaction conditions were optimized for high titers achieved.•Cell-free catalysis led to higher reaction rate, higher product yield and easy product separation.
Full text
Available for:
GEOZS, IJS, IMTLJ, KILJ, KISLJ, NUK, OILJ, PNG, SAZU, SBCE, SBJE, UL, UM, UPCLJ, UPUK, ZRSKP
myo-Inositol belongs to the vitamin B group (vitamin B8) and is widely used in the drug, cosmetic, and food and feed industries. It is produced by acid hydrolysis of phytate, but this method suffers ...from costly feedstock and serious phosphorus pollution. Here a four-enzyme pathway containing thermophilic sucrose phosphorylase, phosphoglucomutase, inositol 1-phosphate synthase, and inositol monophosphatase was designed to convert sucrose to inositol and fructose. To enable the use of enzymes with different optimal temperatures and thermostabilities, we developed a thermal cycling cascade biocatalysis that can selectively add less-thermostable sucrose phosphorylase immobilized on cellulose-containing magnetic nanoparticles into the cold enzyme cocktail or remove it from the hot enzyme cocktail by using a magnetic field (ON/OFF) switch. A series of exergonic reactions push the overall reaction forward, resulting in a high product molar yield (0.98 mol of inositol/mol of sucrose). This cascade biocatalysis platform could open a door to the large-scale production of less-costly inositol and upgrade sucrose to a value-added nutraceutical and functional sweetener.
Full text
Available for:
IJS, KILJ, NUK, PNG, UL, UM
The modified cellulose solvent- (concentrated phosphoric acid) and organic solvent- (95% ethanol) based lignocellulose fractionation (COSLIF) was applied to a naturally-dry moso bamboo sample. The ...biomass dissolution conditions were 50°C, 1atm for 60min. Glucan digestibility was 88.2% at an ultra-low cellulase loading of one filter paper unit per gram of glucan. The overall glucose and xylose yields were 86.0% and 82.6%, respectively. COSLIF efficiently destructed bamboo’s fibril structure, resulting in a ∼33-fold increase in cellulose accessibility to cellulase (CAC) from 0.27 to 9.14m2 per gram of biomass. Cost analysis indicated that a 15-fold decrease in use of costly cellulase would be of importance to decrease overall costs of biomass saccharification when cellulase costs are higher than $0.15 per gallon of cellulosic ethanol.
Full text
Available for:
GEOZS, IJS, IMTLJ, KILJ, KISLJ, NUK, OILJ, PNG, SAZU, SBCE, SBJE, UL, UM, UPCLJ, UPUK
PDF
